3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
10
Recurrence
4
Neurofibrosarcoma
2
Myeloproliferative Disorders
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myeloid, Acute
2
Endometrial Neoplasms
2
Wilms Tumor
1
Vascular Neoplasms
1
Uterine Neoplasms
1
Uterine Diseases
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rhabdoid Tumor
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Neoplasms by Site
1
Neoplasms
1
Myoepithelioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell
1
Lymphoma
1
Liposarcoma, Myxoid
1
Interventions
Capecitabine
22
Oxaliplatin
19
Fluorouracil
16
Radiotherapy
11
Leucovorin
10
Cetuximab
9
Nivolumab
7
Bevacizumab
6
sintilimab
5
Specimen Handling
5
Radiotherapy, Intensity-Modulated
5
Magnetic Resonance Spectroscopy
5
Irinotecan
5
Folfox protocol
5
trifluridine tipiracil drug combination
4
pembrolizumab
4
Surgical Procedures, Operative
4
encorafenib
3
X-Rays
3
Trastuzumab
3
Surveys and Questionnaires
3
Sigmoidoscopy
3
Radiation
3
Pemetrexed
3
Gemcitabine
3
Endoscopy
3
Control Groups
3
Consolidation Chemotherapy
3
Cisplatin
3
Carboplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
selinexor
×
90 days
×
Clear all
No trials found.